EVENTIDE ASSET MANAGEMENT, LLC - 31 Dec 2024 SCHEDULE 13G/A Report for Nektar Therapeutics Common Stock, $0.0001 par value (NKTR)

Filing Manager
EVENTIDE ASSET MANAGEMENT, LLC
Reporting Manager
Eventide Asset Management, LLC
Security
Nektar Therapeutics Common Stock, $0.0001 par value
Symbol
NKTR
Shares outstanding
184M shares
Disclosed Ownership
6.65M shares
Ownership
3.61%
Form type
SCHEDULE 13G/A
Filing time
14 Feb 2025, 12:08:11 UTC
Date of event
31 Dec 2024
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Eventide Asset Management, LLC 3.61% 6.65M 6.65M 0 /s/ Peter J. Luiso Peter J. Luiso, General Counsel
Finny Kuruvilla, M.D., Ph. D. 3.61% 6.65M 0 6.65M /s/ Finny Kuruvilla, M.D., Ph. D. Finny Kuruvilla, M.D., Ph. D.
Robin C. John 3.61% 6.65M 0 6.65M /s/ Robin C. John Robin C. John